HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Parlux expectations soar

This article was originally published in The Rose Sheet

Executive Summary

Third quarter sales are expected to roughly double to $56 mil.-$57 mil., fueled by fragrances under its Paris Hilton, Guess and Maria Sharapova brands, firm announces Jan. 9. Company recorded $28.7 mil. in sales in the prior year period. Fully diluted earnings per share for the quarter are expected to be in the range of $.55-$.57, compared to $.27, Parlux adds. Firm likely will report final Q3 results the second week of February. Separately, firm announces Jan. 11 it will increase its credit line with GMAC Commercial Finance from $20 mil. to $30 mil. with an option to increase to $35 mil. Line has been extended through July 2008. Parlux asked for the increase to support its growth objectives...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013643

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel